is wegovy a glp 1 agonist GLP-1 receptor agonists Holding GLP-1 Agonists Prior to
Description
The promising obesity outcomes enabled by drugs such as Wegovy have prompted other drug manufacturers to pursue their own development efforts to help claim their share of this unprecedented market opportunity
D., Werner, U
Trulicity [package insert]
The first person to be successfully treated was Leonard Thompson (figure 7)
These products are not intended to diagnose, treat, cure, or prevent any disease
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
GLP-1 agonists have also shown strong efficacy in clinical trials, with patients achieving an average weight loss of 15-25%, further promoting rapid adoption
